Short Interest in Esperion Therapeutics, Inc. (NASDAQ:ESPR) Decreases By 6.6%
Esperion Therapeutics, Inc. (NASDAQ:ESPR – Get Free Report) saw a large decline in short interest during the month of November. As of November 15th, there was short interest totalling 31,250,000 shares, a decline of 6.6% from the October 31st total of 33,460,000 shares. Based on an average daily volume of 3,820,000 shares, the days-to-cover ratio […]
More Stories
Headinvest LLC Invests $202,000 in Morgan Stanley (NYSE:MS)
Headinvest LLC purchased a new position in shares of Morgan Stanley (NYSE:MS – Free Report) in the 3rd quarter, according...
LRI Investments LLC Buys 1,396 Shares of Accenture plc (NYSE:ACN)
LRI Investments LLC increased its stake in Accenture plc (NYSE:ACN – Free Report) by 14.6% during the 3rd quarter, according...
Jefferies Financial Group Upgrades Kodiak Sciences (NASDAQ:KOD) to Buy
Kodiak Sciences (NASDAQ:KOD – Get Free Report) was upgraded by Jefferies Financial Group from a “hold” rating to a “buy”...
iShares Russell 1000 Growth ETF (NYSEARCA:IWF) Shares Acquired by LRI Investments LLC
LRI Investments LLC raised its position in shares of iShares Russell 1000 Growth ETF (NYSEARCA:IWF – Free Report) by 101.5%...
Hut 8 (NASDAQ:HUT) Now Covered by Analysts at Cantor Fitzgerald
Cantor Fitzgerald initiated coverage on shares of Hut 8 (NASDAQ:HUT – Get Free Report) in a research report issued to...
Myriad Genetics (NASDAQ:MYGN) Cut to “Market Perform” at Leerink Partners
Myriad Genetics (NASDAQ:MYGN – Get Free Report) was downgraded by research analysts at Leerink Partners from an “outperform” rating to...